UK markets close in 3 hours 4 minutes

HAE Sep 2024 85.000 call

OPR - OPR Delayed price. Currency in USD
Add to watchlist
8.100.00 (0.00%)
As of 02:20PM EDT. Market open.
Full screen
Previous close8.10
Open8.10
Bid0.00
Ask0.00
Strike85.00
Expiry date2024-09-20
Day's range8.10 - 8.10
Contract rangeN/A
Volume4
Open interest41
  • Zacks

    Haemonetics (HAE) Expands VASCADE Line With New Limited Launch

    Haemonetics (HAE) expands its VASCADE portfolio with the limited market release of VASCADE MVP XL vascular closure device.

  • Zacks

    4 Medical Product Stocks to Buy From a Recovering Industry

    Despite the ongoing macro headwinds, recovering demand for medical procedures and cost-cutting initiatives should support the Zacks Medical-Products industry. BSX, RMD, LNTH and HAE are well-poised to gain from the favorable factors.

  • PR Newswire

    Haemonetics Launches Limited Market Release for New VASCADE MVP XL Vascular Closure Device

    Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative solutions to drive better patient outcomes, has launched a limited market release of its new VASCADE MVP® XL mid-bore venous closure device. The VASCADE MVP XL system expands Haemonetics' VASCADE® portfolio of vascular closure systems featuring an innovative collapsible disc technology and a proprietary resorbable collagen patch designed to promote rapid hemostasis.